乳腺癌相关淋巴水肿发病机制及中医药干预研究进展

张宏如; 俞乔; 白子君; 赵薇; 李建; 胡青; 刘顺畅; 陈志行

doi:10.14148/j.issn.1672-0482.2022.0258

乳腺癌相关淋巴水肿发病机制及中医药干预研究进展

doi: 10.14148/j.issn.1672-0482.2022.0258

张宏如^1, ,,
俞乔²,
白子君¹,
赵薇^{1, 3},
李建²,
胡青²,
刘顺畅¹,
陈志行¹

1.
南京中医药大学中医学院·中西医结合学院, 江苏南京 210023
2.
江苏省肿瘤医院乳腺外科, 江苏南京 210009
3.
南通大学附属医院, 江苏南通 226001

基金项目:

南京中医药大学自然科学基金项目 NZY81704169

国家自然科学基金面上项目 81974583

江苏省中医药领军人才项目 SLJ0226

详细信息

通讯作者:
张宏如，男, 副教授，主要从事针灸效应机制研究，E-mail: 170947@njucm.edu.cn

中图分类号: R273
计量
- 文章访问数: 418
- HTML全文浏览量: 109
- PDF下载量: 46
- 被引次数: 0
出版历程
- 收稿日期: 2021-12-16
- 网络出版日期: 2022-03-24
- 发布日期: 2022-03-10

Recent progress of the Pathogenesis of Breast Cancer-Related Lymphedema and Chinese Medicine Intervention

1.
School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
2.
Department of Breast Surgery, Jiangsu Cancer Hospital, Nanjing 210009, China
3.
The Affiliated Hospital of Nantong University, Nantong 226001, China

摘要

摘要: 乳腺癌相关淋巴水肿(BCRL)发病率高、治疗周期长且病情反复、迁延不愈, 对BCRL患者的身心健康造成了严重影响。BCRL病理生理学机制复杂, 本文在分析了BCRL病理过程中淋巴瘀滞、慢性炎症、脂肪组织沉积和纤维化阶段涉及的细胞和分子机制的基础上, 进一步分析BCRL的中医病机特点, 并对现有的治疗策略, 如针刺、艾灸、中医康复、中医药等治疗手段进行了详细阐述, 以期为BCRL的临床合理防治研究提供思路。
- 乳腺癌 /
- 淋巴水肿 /
- 病理生理 /
- 发病机制 /
- 中医药治疗
Abstract: The incidence rate of breast cancer associated lymphoedema (BCRL) is high, the treatment cycle is long, the condition is repeated and the delay is not healed. It has a serious impact on the physical and mental health of BCRL patients. The pathophysiological mechanism of BCRL is complex. Based on the analysis of the cellular and molecular mechanisms involved in the stages of lymph stasis, chronic inflammation, adipose tissue deposition and fibrosis in the pathological process of BCRL, this paper further analyzes the characteristics of TCM pathogenesis of BCRL, and expounds the existing treatment strategies, such as physiotherapy, acupuncture, moxibustion, TCM treatment and so on, It provides ideas for the clinical rational prevention and treatment of BCRL.
- breast cancer /
- lymphedema /
- pathophysiology /
- pathogenesis /
- traditional Chinese medicine treatment

HTML全文

图 1 淋巴水肿发病机制示意图

Figure 1. Schematic diagram of pathogenesis of lymphedema

下载: 全尺寸图片幻灯片

参考文献(69)

[1]	FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386. doi: 10.1002/ijc.29210
[2]	李丹. 50例乳腺癌根治术患者围手术期护理体会[J]. 内蒙古中医药, 2016, 35(3): 142-143. doi: 10.3969/j.issn.1006-0979.2016.03.158 LI D. Perioperative nursing experience of 50 breast cancer patients undergoing radical mastectomy[J]. Nei Mongol J Tradit Chin Med, 2016, 35(3): 142-143. doi: 10.3969/j.issn.1006-0979.2016.03.158
[3]	陈万青, 张思维, 曾红梅, 等. 中国2010年恶性肿瘤发病与死亡[J]. 中国肿瘤, 2014, 23(1): 1-10. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201401001.htm CHEN WQ, ZHANG SW, ZENG HM, et al. Report of cancer incidence and mortality in China, 2010[J]. China Cancer, 2014, 23(1): 1-10. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201401001.htm
[4]	LASINSKI BB, THRIFT KM, SQUIRE D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011[J]. PM&R, 2012, 4(8): 580-601.
[5]	DISIPIO T, RYE S, NEWMAN B, et al. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis[J]. Lancet Oncol, 2013, 14(6): 500-515. doi: 10.1016/S1470-2045(13)70076-7
[6]	TENG HM, YANG YZ, WEI HY, et al. Fucoidan suppresses hypoxia-induced lymphangiogenesis and lymphatic metastasis in mouse hepatocarcinoma[J]. Mar Drugs, 2015, 13(6): 3514-3530. doi: 10.3390/md13063514
[7]	LAWENDA BD, MONDRY TE, JOHNSTONE PAS. Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment[J]. CA A Cancer J Clin, 2009, 59(1): 8-24. doi: 10.3322/caac.20001
[8]	VIGNES S, ARRAULT M, DUPUY A. Factors associated with increased breast cancer-related lymphedema volume[J]. Acta Oncol, 2007, 46(8): 1138-1142. doi: 10.1080/02841860701403020
[9]	胡书源, 柳弥. 乳腺癌上肢淋巴水肿的研究进展[J]. 肿瘤预防与治疗, 2021, 34(3): 262-268. doi: 10.3969/j.issn.1674-0904.2021.03.013 HU SY, LIU M. Research progress of upper limb lymphedema in breast cancer[J]. J Cancer Control Treat, 2021, 34(3): 262-268. doi: 10.3969/j.issn.1674-0904.2021.03.013
[10]	ADAMS KE, RASMUSSEN JC, DARNE C, et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema[J]. Biomed Opt Express, 2010, 1(1): 114. doi: 10.1364/BOE.1.000114
[11]	PETREK JA, SENIE RT, PETERS M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis[J]. Cancer, 2001, 92(6): 1368-1377. doi: 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9
[12]	TAGHIAN NR, MILLER CL, JAMMALLO LS, et al. Lymphedema following breast cancer treatment and impact on quality of life: A review[J]. Crit Rev Oncol, 2014, 92(3): 227-234. doi: 10.1016/j.critrevonc.2014.06.004
[13]	朱倩男, 夏添松, 凌立君, 等. 乳腺癌术后上肢淋巴水肿发生机制及预防进展[J]. 中华乳腺病杂志(电子版), 2013, 7(6): 442-445. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHRD201306010.htm ZHU QN, XIA TS, LING LJ, et al. Progress in pathogenesis and prevention of upper limb lymphedema after breast cancer surgery[J]. Chin J Breast Dis Electron Ed, 2013, 7(6): 442-445. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHRD201306010.htm
[14]	王健理, 姚德生. 妇科恶性肿瘤淋巴结清扫术后下肢淋巴水肿发病机制的研究进展[J]. 现代妇产科进展, 2019, 28(11): 864-868. WANG JL, YAO DS. Research progress on the pathogenesis of lymphedema of lower extremities after lymph node dissection for gynecological malignant tumors[J]. Prog Obstet Gynecol, 2019, 28(11): 864-868.
[15]	何玉龙, 朱元贵, 李伯良, 等. 淋巴管系统相关研究现状与展望[J]. 科学通报, 2017, 62(10): 1030-1040. HE YL, ZHU YG, LI BL, et al. Progress and prospect of lymphangiogenesis research[J]. Chin Sci Bull, 2017, 62(10): 1030-1040.
[16]	李喆, 葛海燕. 乳腺癌根治术后上肢淋巴水肿的研究进展[J]. 中华乳腺病杂志(电子版), 2012, 6(2): 201-208. doi: 10.3877/cma.j.issn.1674-0807.2012.02.012 LI Z, GE HY. Research progress of upper limb lymphedema after radical mastectomy[J]. Chin J Breast Dis Electron Ed, 2012, 6(2): 201-208. doi: 10.3877/cma.j.issn.1674-0807.2012.02.012
[17]	BATES DO. An interstitial hypothesis for breast cancer related lymphoedema[J]. Pathophysiology, 2010, 17(4): 289-294. doi: 10.1016/j.pathophys.2009.10.006
[18]	RUOCCO E, PUCA RV, BRUNETTI G, et al. Lymphedematous areas: Privileged sites for tumors, infections, and immune disorders[J]. Int J Dermatol, 2007, 46(6): 662. doi: 10.1111/j.1365-4632.2007.03244.x
[19]	HOEBEN A, LANDUYT B, HIGHLEY MS, et al. Vascular endothelial growth factor and angiogenesis[J]. Pharmacol Rev, 2004, 56(4): 549-580. doi: 10.1124/pr.56.4.3
[20]	SAARIKKO A, HARTIALA P. Lymphangiogenesis and lymphangiogenic growth factors[J]. J Reconstr Microsurg, 2015, 32(1): 10-15. doi: 10.1055/s-0035-1544179
[21]	SAARISTO A, VEIKKOLA T, TAMMELA T, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects[J]. J Exp Med, 2002, 196(6): 719-730. doi: 10.1084/jem.20020587
[22]	LILIANA C, SANJAY N, WEI L, et al. Hyperbaric oxygen therapy for large composite grafts: An alternative in pediatric facial reconstruction[J]. J Plast Reconstr Aesthetic Surg, 2020, 73(12): 2178-2184. doi: 10.1016/j.bjps.2020.05.028
[23]	GHANTA S, CUZZONE DA, TORRISI JS, et al. Regulation of inflammation and fibrosis by macrophages in lymphedema[J]. Am J Physiol Heart Circ Physiol, 2015, 308(9): H1065-H1077. doi: 10.1152/ajpheart.00598.2014
[24]	GARDENIER JC, HESPE GE, KATARU RP, et al. Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema[J]. JCI Insight, 2016, 1(15): 1-13.
[25]	GHANTA S, CUZZONE DA, TORRISI JS, et al. Regulation of inflammation and fibrosis by macrophages in lymphedema[J]. Am J Physiol Heart Circ Physiol, 2015, 308(9): H1065-H1077. doi: 10.1152/ajpheart.00598.2014
[26]	ZAMPELL JC, YAN AL, ELHADAD S, et al. CD4⁺ cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis[J]. PLoS One, 2012, 7(11): e49940. doi: 10.1371/journal.pone.0049940
[27]	AVRAHAM T, ZAMPELL JC, YAN AL, et al. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema[J]. FASEB J, 2013, 27(3): 1114-1126. doi: 10.1096/fj.12-222695
[28]	ZAMPELL JC, YAN AL, ELHADAD S, et al. CD4⁺ cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis[J]. PLoS ONE, 2012, 7(11): e49940. doi: 10.1371/journal.pone.0049940
[29]	SAVETSKY IL, GHANTA S, GARDENIER JC, et al. Th2 cytokines inhibit lymphangiogenesis[J]. PLoS ONE, 2015, 10(6): e0126908. doi: 10.1371/journal.pone.0126908
[30]	LIAO S, CHENG G, CONNER DA, et al. Impaired lymphatic contraction associated with immunosuppression[J]. Proc Natl Acad Sci USA, 2011, 108(46): 18784-18789. doi: 10.1073/pnas.1116152108
[31]	TORRISI JS, HESPE GE, CUZZONE DA, et al. Inhibition of inflammation and iNOS improves lymphatic function in obesity[J]. Sci Rep, 2016, 6: 19817. doi: 10.1038/srep19817
[32]	COLGAN SP, FURUTA GT, TAYLOR CT. Hypoxia and innate immunity: Keeping up with the HIFsters[J]. Annu Rev Immunol, 2020, 38: 341-363. doi: 10.1146/annurev-immunol-100819-121537
[33]	JIANG XG, TIAN W, GRANUCCI EJ, et al. Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema[J]. J Clin Investig, 2020, 130(10): 5562-5575. doi: 10.1172/JCI136164
[34]	COUTO RA, KULUNGOWSKI AM, CHAWLA AS, et al. Expression of angiogenic and vasculogenic factors in human lymphedematous tissue[J]. Lymphatic Res Biol, 2011, 9(3): 143-149. doi: 10.1089/lrb.2011.0008
[35]	JIANG XG, TIAN W, GRANUCCI EJ, et al. Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema[J]. J Clin Investig, 2020, 130(10): 5562-5575. doi: 10.1172/JCI136164
[36]	ZALESKA MT, OLSZEWSKI WL. Serum immune proteins in limb lymphedema reflecting tissue processes caused by lymph stasis and chronic dermato-lymphangio-adenitis (cellulitis)[J]. Lymphatic Res Biol, 2017, 15(3): 246-251. doi: 10.1089/lrb.2017.0003
[37]	SHIMIZU Y, SHIBATA R, ISHⅡ M, et al. Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema[J]. J Am Heart Assoc, 2013, 2(5): 1-11.
[38]	TAMMELA T, ALITALO K. Lymphangiogenesis: Molecular mechanisms and future promise[J]. Cell, 2010, 140(4): 460-476. doi: 10.1016/j.cell.2010.01.045
[39]	ASCHEN S, ZAMPELL JC, ELHADAD S, et al. Regulation of adipogenesis by lymphatic fluid stasis[J]. Plast Reconstr Surg, 2012, 129(4): 838-847. doi: 10.1097/PRS.0b013e3182450b47
[40]	ROCKEY DC, BELL PD, HILL JA. Fibrosis: A common pathway to organ injury and failure[J]. N Engl J Med, 2015, 372(12): 1138-1149. doi: 10.1056/NEJMra1300575
[41]	TASHIRO K, FENG J, WU SH, et al. Pathological changes of adipose tissue in secondary lymphoedema[J]. Br J Dermatol, 2017, 177(1): 158-167. doi: 10.1111/bjd.15238
[42]	OBERRINGER M, MEINS C, BUBEL M, et al. In vitro wounding: Effects of hypoxia and transforming growth factor β1 on proliferation, migration and myofibroblastic differentiation in an endothelial cell-fibroblast co-culture model[J]. J Mol Histol, 2008, 39(1): 37-47. doi: 10.1007/s10735-007-9124-3
[43]	VITTET D, MERDZHANOVA G, PRANDINI MH, et al. TGF β1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells[J]. J Cell Physiol, 2012, 227(11): 3593-3602. doi: 10.1002/jcp.24063
[44]	WYNN TA. Cellular and molecular mechanisms of fibrosis[J]. J Pathol, 2008, 214(2): 199-210. doi: 10.1002/path.2277
[45]	AVRAHAM T, DALUVOY S, ZAMPELL J, et al. Blockade of transforming growth factor-β1 accelerates lymphatic regeneration during wound repair[J]. Am J Pathol, 2010, 177(6): 3202-3214. doi: 10.2353/ajpath.2010.100594
[46]	AVRAHAM T, ZAMPELL JC, YAN AL, et al. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema[J]. FASEB J, 2013, 27(3): 1114-1126. doi: 10.1096/fj.12-222695
[47]	KATARU RP, KIM H, JANG C, et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation[J]. Immunity, 2011, 34(1): 96-107. doi: 10.1016/j.immuni.2010.12.016
[48]	黄帝内经[M]. 北京: 中华书局出版社, 2014: 354. The Yellow Emperor's Inner Classic[M]. Beijing: Zhonghua book publishing house, 2014: 354.
[49]	巢元方. 诸病源候论[M]. 北京: 中国医药科技出版社, 2011: 132. CHAO YF. Treatise on the Origins and Manifestations of Various Diseases[M]. Beijing: China medical and technology press, 2011: 132.
[50]	吴谦. 医宗金鉴[M]. 北京: 中国医药科技出版社, 2011: 204. WU Q. Golden Mirror of the Medical Tradition[M]. Beijing: China medical and technology press, 2011: 204.
[51]	张仲景. 金匮要略[M]. 北京: 中国医药科技出版社, 2016: 287. ZHANG ZJ. Essentials from the Golden Cabinet[M]. Beijing: China medical and technology press, 2016: 287.
[52]	杨美凤, 宋建平. 《金匮要略》血不利则为水之我见[J]. 陕西中医, 2008, 29(8): 1047, 1101. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZY200808078.htm YANG MF, SONG JP. Synopsis of the Golden Chamber My opinion of water is disadvantageous to blood[J]. Shaanxi J Tradit Chin Med, 2008, 29(8): 1047, 1101. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZY200808078.htm
[53]	战祥毅, 隋鑫, 王文萍. 中医治疗乳腺癌术后上肢淋巴水肿研究进展[J]. 临床军医杂志, 2017, 45(2): 216-220. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ201702030.htm ZHAN XY, SUI X, WANG WP. Research progress in the treatment of upper limb lymphedema after breast cancer by traditional Chinese medicine[J]. Clin J Med Off, 2017, 45(2): 216-220. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ201702030.htm
[54]	HOU WZ, PEI LX, SONG YF, et al. Acupuncture therapy for breast cancer-related lymphedema: A systematic review and meta-analysis[J]. J Obstet Gynaecol Res, 2019, 45(12): 2307-2317. doi: 10.1111/jog.14122
[55]	BAO T, IRIS ZHI W, VERTOSICK EA, et al. Acupuncture for breast cancer-related lymphedema: A randomized controlled trial[J]. Breast Cancer Res Treat, 2018, 170(1): 77-87. doi: 10.1007/s10549-018-4743-9
[56]	WANG CH, YANG M, FAN YY, et al. Moxibustion as a therapy for breast cancer-related lymphedema in female adults: A preliminary randomized controlled trial[J]. Integr Cancer Ther, 2019, 18: 153473541986691.
[57]	YEH CH, ZHAO TY, ZHAO MD, et al. Comparison of effectiveness between warm acupuncture with local-distal points combination and local distribution points combination in breast cancer-related lymphedema patients: A study protocol for a multicenter, randomized, controlled clinical trial[J]. Trials, 2019, 20: 403. doi: 10.1186/s13063-019-3491-4
[58]	MCNEELY ML, CAMPBELL KL, WEBSTER M, et al. Efficacy of night-time compression for breast cancer related lymphedema (LYNC): Protocol for a multi-centre, randomized controlled efficacy trial[J]. BMC Cancer, 2016, 16: 601. doi: 10.1186/s12885-016-2648-8
[59]	RANGON FB, DA SILVA J, DIBAI-FILHO AV, et al. Effects of complex physical therapy and multimodal approaches on lymphedema secondary to breast cancer: A systematic review and meta-analysis of randomized controlled trials[J]. Arch Phys Med Rehabilitation, 2022, 103(2): 353-363. doi: 10.1016/j.apmr.2021.06.027
[60]	范洪桥, 刘丽芳, 周亮, 等. 从"血不利则为水"论乳腺癌术后上肢淋巴水肿的中医证治[J]. 时珍国医国药, 2020, 31(3): 657-659. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY202003048.htm FAN HQ, LIU LF, ZHOU L, et al. Treatment of arm lymphedema following breast cancer surgery with "unsmooth blood circulation results in water retention"[J]. Lishizhen Med Mater Med Res, 2020, 31(3): 657-659. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY202003048.htm
[61]	连粉红, 夏小军, 郭炳涛, 等. 基于"血不利则为水"理论探讨乳腺癌术后上肢淋巴水肿辨治[J]. 中国中医基础医学杂志, 2020, 26(4): 556-558. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC202004045.htm LIAN FH, XIA XJ, GUO BT, et al. Discussion on the treatment of upper limb lymphedema after breast cancer operation based on the theory of "Unsmooth Blood Circulation Results in Water Retention"[J]. J Basic Chin Med, 2020, 26(4): 556-558. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC202004045.htm
[62]	SHEIKHI-MOBARAKEH Z, YARMOHAMMADI H, MOKHATRI-HESARI P, et al. Herbs as old potential treatments for lymphedema management: A systematic review[J]. Complement Ther Med, 2020, 55: 102615. doi: 10.1016/j.ctim.2020.102615
[63]	ZHU HR, PENG Z, DAI MY, et al. Efficacy and safety of Wuling San for treatment of breast-cancer-related upper extremity lymphoedema: Study protocol for a pilot trial[J]. BMJ Open, 2016, 6(12): e012515. doi: 10.1136/bmjopen-2016-012515
[64]	霍岩. 自拟消肿汤对乳腺癌术后上肢淋巴水肿的效果评价[J]. 当代医学, 2018, 24(22): 118-119. doi: 10.3969/j.issn.1009-4393.2018.22.049 HUO Y. Effect of self-made digestion Decoction on lymphedema of upper limb in postoperative patients with breast cancer[J]. Contemp Med, 2018, 24(22): 118-119. doi: 10.3969/j.issn.1009-4393.2018.22.049
[65]	OGATA F, FUJIU K, MATSUMOTO S, et al. Excess lymphangiogenesis cooperatively induced by macrophages and CD4⁺T cells drives the pathogenesis of lymphedema[J]. J Investig Dermatol, 2016, 136(3): 706-714. doi: 10.1016/j.jid.2015.12.001
[66]	ZAMPELL JC, ASCHEN S, WEITMAN ES, et al. Regulation of adipogenesis by lymphatic fluid stasis[J]. Plast Reconstr Surg, 2012, 129(4): 825-834. doi: 10.1097/PRS.0b013e3182450b2d
[67]	KATARU RP, WISER I, BAIK JE, et al. Fibrosis and secondary lymphedema: Chicken or egg?[J]. Transl Res, 2019, 209: 68-76. doi: 10.1016/j.trsl.2019.04.001
[68]	CASSILETH BR, VAN ZEE KJ, CHAN Y, et al. A safety and efficacy pilot study of acupuncture for the treatment of chronic lymphoedema[J]. Acupunct Med, 2011, 29(3): 170-172. doi: 10.1136/aim.2011.004069
[69]	SMITH CA, PIROTTA M, KILBREATH S. A feasibility study to examine the role of acupuncture to reduce symptoms of lymphoedema after breast cancer: A randomised controlled trial[J]. Acupunct Med, 2014, 32(5): 387-393. doi: 10.1136/acupmed-2014-010593